Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
SilverBox Corp IV Class A ( (SBXD) ) just unveiled an update.
On June 20, 2025, Parataxis Holdings LLC announced a definitive agreement to acquire a controlling interest in Bridge Biotherapeutics, Inc., a Korean company listed on the KOSDAQ, with plans to establish a Bitcoin-native treasury platform in South Korea. This strategic move aims to enhance institutional access to Bitcoin exposure and is expected to benefit shareholders and the South Korean market by leveraging the increasing global interest in BTC treasury strategies.
More about SilverBox Corp IV Class A
SilverBox Corp IV is involved in strategic business combinations and investments, while Parataxis Holdings LLC, an affiliate of Parataxis Capital Management, focuses on BTC treasury and digital asset investment opportunities. Parataxis Capital Management is a multi-strategy investment firm centered on the digital asset sector, managing hedge fund vehicles and providing advisory services. Bridge Biotherapeutics, Inc. is a clinical stage biotech company developing therapeutics for ulcerative colitis, fibrotic diseases, and cancers, and is listed on the KOSDAQ.
Average Trading Volume: 102,893
Technical Sentiment Signal: Strong Buy
Learn more about SBXD stock on TipRanks’ Stock Analysis page.